INS and Hyperglycemia: Within two hours after injections, higher blood glucose levels (hyperglycemia) were observed in mice that received anti-insulin IgMlow, while anti-insulin IgMhigh did not alter blood glucose and was able to protect insulin from IgG-dependent degradation (Figure 1D).